ARCHIVES

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

This article is from The Cancer Letter archive.

Vol. 04 No. 37 | September 15, 1978

Download PDF Visit The Full Archive

Related Articles

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

In Brief: Wells, Gardner, Brennan Lead Surgical Oncology; Young, Flynn, Are New officers For Head & Neck

March 26, 1993

Rauscher Decision Put Off To July 1: Administration Backs Pay Raise Bill

June 25, 1976

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012